Pretreatment level of serum sialic acid predicts both qualitative and quantitative bone metastases of prostate cancer.

Background: Recently, serum sialic acid (SA) has emerged as a distinct prognostic marker for prostate cancer (PCa) and bone metastases, warranting differential treatment and prognosis for low-volume (LVD) and high-volume disease (HVD). In clinical settings, evaluating bone metastases can prove advantageous. Objectives: We aimed to establish the correlation between SA and both bone metastasis and HVD in newly diagnosed PCa patients. Methods: We conducted a retrospective analysis of 1202 patients who received a new diagnosis of PCa between November 2014 and February 2021. We compared pretreatment SA levels across multiple groups and investigated the associations between SA levels and the clinical parameters of patients. Additionally, we compared the differences between HVD and LVD. We utilized several statistical methods, including the non-parametric Mann-Whitney U test, Spearman correlation, receiver operating characteristic (ROC) curve analysis, and logistic regression. Results: The results indicate that SA may serve as a predictor of bone metastasis in patients with HVD. ROC curve analysis revealed a cut-off value of 56.15 mg/dL with an area under the curve of 0.767 (95% CI: 0.703-0.832, P < 0.001) for bone metastasis versus without bone metastasis and a cut-off value of 65.80 mg/dL with an area under the curve of 0.766 (95% CI: 0.644-0.888, P = 0.003) for HVD versus LVD. Notably, PCa patients with bone metastases exhibited significantly higher SA levels than those without bone metastases, and HVD patients had higher SA levels than LVD patients. In comparison to the non-metastatic and LVD cohorts, the cohort with HVD exhibited higher levels of alkaline phosphatase (AKP) (median, 122.00 U/L), fibrinogen (FIB) (median, 3.63 g/L), and prostate-specific antigen (PSA) (median, 215.70 ng/mL), as well as higher Gleason scores (> 7). Multivariate logistic regression analysis demonstrated that an SA level of > 56.15 mg/dL was independently associated with the presence of bone metastases in PCa patients (OR = 2.966, P = 0.018), while an SA level of > 65.80 mg/dL was independently associated with HVD (OR = 1.194, P = 0.048). Conclusion: The pretreatment serum SA level is positively correlated with the presence of bone metastases.

Synthesis, structure, topology and magnetic properties of cobalt(II) coordination polymers with 2-nitrobiphenyl-4,4'-dicarboxylic acid and bis(pyridyl) ligands.

Four coordination polymers, [Co2(Hnbpdc)2(nbpdc)(bipy)2]n (1), [Co3(nbpdc)3(bipy)3(H2O)2]n·2nH2O (2), [Co4(nbpdc)4(bipy)(H2O)4]n (3), and [Co2(nbpdc)2(bpee)(3/2)]n·0.25nH2O (4) [H2nbpdc = 2-nitrobiphenyl-4,4'-dicarboxylic acid, bipy = 4,4'-bipyridine and bpee = 1,2-di(4-pyridyl)ethane] have been synthesized by hydrothermal methods and studied by means of X-ray crystallography, topological analyses and magnetic analyses. Compounds 1­3 were synthesized from the same reactants under controlled conditions (pH and ligand ratio). Compounds 1, 2 and 4 contain bis(carboxylate)-bridged dinuclear motifs as secondary building units (SBUs). In 1 and 2 the SBUs are connected into 44 layers by bis(chelating) nbpdc and pairwise bipy linkers. In 1, the layers are pillared into a 3D framework with the pcu topology by Hnbpdc, which is coordinated to one layer and hydrogen-bonded to another layer. In 2, the layers and the linear [Co(bipy)]n chains intercalated between the layers are connected by nbpdc to produce a 3D framework exhibiting a rarely observed 4,6-connected topology. In 4 the SBUs are connected by nbpdc [bis(chelating) and bis(bridging)] and bpee (single and pairwise) to yield a 3D framework, which defines a new 6-connected net with point symbol (4(10)·5(2)·6(3)). Notably, this new net and the known hex-6-P6(2)22 net represent the first examples of topologically different nets having the same coordination sequences, point and vertex symbols. Compound 3 contains carboxylate- and aqua-bridged tetranuclear motifs as SBUs, which are connected by covalent linkers (nbpdc and bipy) and sextuple O­H···O hydrogen bonds to generate a 3D framework, which defines a new 10-connected net with point symbol (4(24)·5(12)·6(8)·7) (considering only covalent linkers) and a new 12-connected net with point symbol (3(12)·4(36)·5(17)·6) (including also the hydrogen bonds as linkers). Magnetic studies on 1 and 2 demonstrated that the bis(syn­skew-carboxylate) bridges between octahedral Co(II) ions induce ferromagnetic coupling; 4 is peculiar in that octahedral and tetrahedral Co(II) ions are linked by mixed syn­syn and syn­skew carboxylate bridges, which give rise to antiferromagnetic coupling.

Solvent-modulated metamagnetism in a nickel(ii) coordination polymer with mixed azide and carboxylate bridges.

A novel 2D coordination polymer consisting of ferromagnetic Ni(ii) chains with alternating double EO-azide bridges and (EO-azide)bis(carboxylate) triple bridges exhibits solvent-modulated metamagnetism, and the reversible dehydration/hydration processes are accompanied by significant changes in critical temperature, critical field and hysteresis.

Bis[3-(2-carboxy-ethen-yl)pyridinium-1-acetato]dichloridozinc(II).

In the title complex, [ZnCl(2)(C(10)H(9)NO(4))(2)], the Zn(II) ion lies on a twofold rotation axis and is four-coordinated by two carboxyl-ate O atoms from two 3-(2-carboxy-ethen-yl)pyridinium-1-acetate ligands in a monodentate mode and two Cl atoms in a distorted tetra-hedral geometry. In the crystal structure, inter-molecular O-H⋯O hydrogen bonds link the mol-ecules into a double-chain structure extending parallel to [101].